Showing results (161-170 of 212) with videos related to

Sort By:
Pageof 22
BMC Nephrology|June 10, 2018
C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: case reportJuana Alonso-Titos, Lara Perea-Ortega, Eugenia Sola, et al.
Cirugia Espanola|November 21, 2007
[Adverse events in general and digestive surgery departments in Spanish hospitals]Jesús M Aranaz-Andrés, Pedro Ruiz-López, Carlos Aibar-Remón, et al.
Journal of Clinical Medicine|November 13, 2021
Decrease in CD14++CD16+ Monocytes in Low-Immunological-Risk Kidney Transplant Patients with Subclinical Borderline InflammationAbelardo Caballero, Teresa Vazquez-Sanchez, Pedro Ruiz-Esteban, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 6, 2024
Identification of non-actionable mutations with prognostic and predictive value in patients with advanced or metastatic non-small cell lung cancerMariano Provencio-Pulla, Diego Pérez-Parente, Sara Olson, et al.
European Journal of Internal Medicine|September 10, 2024
Predictors of pulmonary embolism in chronic obstructive pulmonary diseases patients admitted for worsening respiratory symptoms: An individual participant data meta-analysesValentine Mismetti, Francis Couturaud, Olivier Sanchez, et al.
International Journal of Molecular Sciences|August 29, 2024
The Role of the Gut Microbiota in Sanfilippo Syndrome's Physiopathology: An Approach in Two Affected SiblingsRaquel Barbero-Herranz, María Garriga-García, Ana Moreno-Blanco, et al.
The American Journal of Medicine|March 31, 2025
Comparative Validation of Risk Assessment Models for Venous Thromboembolism Risk in Hospitalized Medical Patients: Insights from a Multicenter Prospective Cohort StudyPedro Ruiz-Artacho, Mónica Olid Velilla, Fahd Beddar Chaib, et al.
Transplantation|June 1, 2014
Clinical assessment of mortality risk in renal transplant candidates in SpainDomingo Hernández, Pablo Castro de la Nuez, Alfonso Muriel, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2022
Development of BRD4 inhibitors as anti-inflammatory agents and antidotes for arsenicalsMarina Fosso Yatchang, Bini Mathew, Ritesh K Srivastava, et al.
Pageof 22